News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Edison Expands European Biotech Presence with Initiation of Research Coverage on TRANSGENE (TRGNY)


1/17/2012 9:16:46 AM

LONDON--(BUSINESS WIRE)--Edison Investment Research, a UK-based independent equity research firm, announces the initiation of research coverage on Transgene (NYSE Euronext Paris: TNG), a French immunotherapy drug discovery and development company.

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES